GLPwatch
Trials (2139)
Page 20 of 36.
- Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
- Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesity
- A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
- A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy Participants
- The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity
- A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity
- Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
- Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide.
- A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight
- Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis
- Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)
- Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years
- Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide
- Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1
- Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control
- Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI
- Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy
- IDegLira HIGH Trial
- A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)
- Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes
- A Study of LY3457263 in Obese Participants
- A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
- A Study of LY3493269 in Participants With Type 2 Diabetes
- Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium
- A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
- A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers
- LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.
- LIraglutide and Beta-cell RepAir (LIBRA) Study
- Pharmacokinetics of IBI362 in Subjects With and Without Renal Impairment
- Liraglutide in Type 1 Diabetes
- The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
- A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic Drugs
- Lifestyle Modification and Liraglutide
- A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
- Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes
- The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes
- A Long-term Safety Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
- Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
- Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
- Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes
- Multiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes Mellitus
- A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity
- A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
- COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial
- A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes
- Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia
- Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)
- Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
- A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes
- Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function
- A Research Study Comparing the Effect of Different Dosing Conditions on Blood Levels of Semaglutide in a New Tablet Composition in Healthy Participants
- A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes
- Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- Metformin
- Daily Liraglutide for Nicotine Dependence
- Metabolism and Excretion of Liraglutide in Healthy Male Volunteers
- Epicardial Cardiac Fat-CT (EPIC-CT)
- The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
- Comparison of Two Liraglutide Formulations in Healthy Volunteers
- Genetics of the Acute Response to Oral Semaglutide